ATP synthase inhibitor

This page covers all ATP synthase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Mycobacterial ATP synthase.

Targets

Mycobacterial ATP synthase

Marketed (1)

• Bedaquiline (B) · Shenzhen Third People's Hospital · Infectious Disease
  Bedaquiline inhibits bacterial ATP synthase, disrupting energy production in Mycobacterium tuberculosis.

Phase 3 pipeline (2)

• Bedaquiline Oral Tablet · Wits Health Consortium (Pty) Ltd · Infectious Disease
  Bedaquiline inhibits bacterial ATP synthase, disrupting energy production in Mycobacterium tuberculosis.
• BE-PEP Bedaquiline · Institute of Tropical Medicine, Belgium · Infectious Disease
  Bedaquiline inhibits bacterial ATP synthase, disrupting energy production in Mycobacterium tuberculosis.